SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Feline Virus, Antiviral Drug Studied by Ohio State University Researchers to Understand Drug Resistance
October 11, 2007
 · 
1 min read
Drug Development
Study Shows Persistent Benefits of Statin Drug
October 11, 2007
 · 
1 min read
Drug Development
Weizmann Institute of Science Scientists Identify: Genes That Affect Responses of Multiple Sclerosis Patients to Copaxone(R)
October 10, 2007
 · 
1 min read
Drug Development
Epilepsy Drug Helps Alcoholics Quit the Bottle, University of Virginia Study
October 10, 2007
 · 
1 min read
Drug Development
Ultra-Low-Dose Aspirin Might Decrease Bleeding Severity in Portal Hypertension
October 10, 2007
 · 
1 min read
Drug Development
Antidepressants and Painkillers - a Dangerous Combination
October 9, 2007
 · 
1 min read
Drug Development
Drug Cocktail Stops Brain Damage Caused by HIV
October 9, 2007
 · 
1 min read
Drug Development
Vaccine Lessens Severity of Pneumonia, Study Finds
October 9, 2007
 · 
1 min read
Drug Development
Thalidomide Helps Elderly Cancer Patients: Study
October 8, 2007
 · 
1 min read
Drug Development
New Cancer Drugs Could Help in Autoimmune Disease
October 8, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Boehringer Ingelheim Corporation: Dabigatran Etexilate is Cost-Effective for Stroke Prevention in Atrial Fibrillation
March 24, 2011
 · 
11 min read
Drug Development
Amgen Says Prolia Increases Bone Density Over Time
March 24, 2011
 · 
14 min read
Drug Development
Novartis AG, Roche’s Xolair Helps Kids With Severe Milk Allergies
March 22, 2011
 · 
1 min read
Drug Development
GlaxoSmithKline’s Avandia Linked with Heart Risk Again
March 18, 2011
 · 
1 min read
Drug Development
Novartis AG, Roche’s Xolair Blunts Asthma Attacks in Children in U.S. Cities
March 17, 2011
 · 
1 min read
Drug Development
Teva Pharmaceutical Industries Limited Says Doctors Contacted on Trial of Generic Copaxone Drug
March 8, 2011
 · 
1 min read
Drug Development
Johnson & Johnson’s Risperdal Consta No More Effective for Schizophrenia Than Cheaper Treatments in Study
March 4, 2011
 · 
1 min read
Drug Development
GlaxoSmithKline Drug Not Tied to Heart Risks by FDA, Challenging Studies
March 2, 2011
 · 
1 min read
Drug Development
Merck & Co., Inc.'s ISENTRESS(R) (raltegravir) Demonstrated Durable Reductions in HIV-1 Viral Load and Sustained Tolerability At Three Years of Treatment in Previously Untreated Adult Patients Infected with HIV-1
March 1, 2011
 · 
11 min read
Drug Development
Zogenix, Inc. to Present SUMAVEL(R) DosePro(TM) Phase 4 Results at American Academy of Neurology
March 1, 2011
 · 
1 min read
Drug Development
Pfizer Inc.'s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases
February 24, 2011
 · 
1 min read
Drug Development
Elan Corporation PLC, Biogen Idec, Inc. (Massachusetts) Tysabri Reports 10 More Brain Disease Cases
February 22, 2011
 · 
1 min read
Drug Development
Roche’s Cancer Drug Could Prevent Blindness in Preemies
February 17, 2011
 · 
1 min read
Drug Development
Depomed, Inc. Hit by FDA Request for Extra Info on Pain Drug
February 16, 2011
 · 
1 min read
Drug Development
Pacira Pharmaceuticals, Inc. Highlights Additional Safety Data on EXPAREL(TM) for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
February 15, 2011
 · 
6 min read
Drug Development
Novartis AG’s Onbrez Plus Rival, Pfizer Inc.'s Drug Boosts Lung Function
February 10, 2011
 · 
1 min read
Drug Development
World Health Organization: Further Investigation Needed into GlaxoSmithKline’s Pandemrix, Narcolepsy Link to Flu Shots Not Clear
February 9, 2011
 · 
1 min read
Drug Development
AstraZeneca PLC, Johnson & Johnson Drugs for Schizophrenia May Exacerbate Loss of Brain Tissue, Study Finds
February 8, 2011
 · 
1 min read
Drug Development
Genentech: Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
February 8, 2011
 · 
13 min read
Drug Development
Merck & Co., Inc.’s Gardasil Prevents HPV Infection, Genital Warts in Men
February 3, 2011
 · 
1 min read
Load More